Dear Colleagues,

Radiopharmaceuticals are radioisotope containing pharmaceuticals including all physicochemically characterized molecular structures such as small organic molecules, coordination compounds, nanomaterials. Research on radiopharmaceutical developments centers on radiopharmaceutical design and preparation for in vitro and in vivo biological applications, radioisotopes labeling chemical compounds as nuclear medicine for preclinical and clinical studies. 

This Special Issue will focus on the development of radiopharmaceuticals for their theranostic applications. Development of radiopharmaceuticals includes but not limited to: 1) radiolabeling techniques such as radiosynthesis, purification, 2) pharmacological investigations, 3) radiotracers (nuclear imaging probes) for PET/SPECT, 4) preclinical or clinical trials, theranostic applications, and potential personalized medicine as well.